Is. Klasen et al., THE PRESENCE OF PEPTIDOGLYCAN POLYSACCHARIDE COMPLEXES IN THE BOWEL WALL AND THE CELLULAR-RESPONSES TO THESE COMPLEXES IN CROHNS-DISEASE, Clinical immunology and immunopathology, 71(3), 1994, pp. 303-308
Interestingly, using a monoclonal antibody, peptidoglycan-polysacchari
de complexes (PPC) were detected intracellularly in the mucosa and sub
mucosa of the bowel wall of Crohn's disease (CD) patients. PPC are the
main constituents of the gram-positive bacterial cell wall. These PPC
were however detected in the normal bowel wall also. Therefore, in th
is study the hypothesis that an enhanced immune responsiveness to bact
erial antigens plays a pivotal role in the induction or the chronicity
of CD was tested. As antigens, the peptidoglycan structures of intest
inal bacteria (Eubacterium aerofaciens or fecal PPC) or of Streptococc
us pyogenes, the 65-kDa heat shock protein and muramyl dipeptide (MDP)
, the smallest bioactive subunit of peptidoglycan, were used. The prol
iferative responses of peripheral blood (PB) mononuclear cells (MNC) o
f healthy subjects and patients in a remissive stage of CD or an activ
e CD stage were examined. Of this last patient group the MNC responses
of the mesenterial lymph nodes that drain the inflamed gut area were
measured also. The responses of PB-MNC of the healthy subjects and the
patients in a remissive CD stage were not different. Compared to the
responses in remissive CD, the PB-MNC responses in active CD to the eu
bacterial cell wall and streptococcal cell wall antigen were significa
ntly higher. At the inflammation site in active CD, the lymph nodes, t
he responses to most of the bacterial antigens were significantly high
er than in the PB. In summary, the results show the presence of bacter
ial peptidoglycan in the bowel wall and the immune responsiveness, esp
ecially at the inflammation site, to these antigens in active CD and t
herefore present suggestive evidence for the role of peptidoglycan in
the etiology and/or pathogenesis of CD. (C) 1994 Academic Press, Inc.